Concepedia

Kristine L. Stump

KL

Statistics

Publications

8

Citations

339

H-Index

8

Active since

2010

Affiliations

Worldwide Clinical Trials (United States)(Current)

Kristine L. Stump is an author at Worldwide Clinical Trials (United States) specializing in medicine, pharmacology, and cytokine biology.

Publications per year

2010–2012

8

Publications

8

A highly selective, orally active inhibitor of Janus kinase 2, CEP-33779, ablates disease in two mouse models of rheumatoid arthritis

Kristine L. Stump, Lily Lu, Paweł Dobrzański et al. · Arthritis Research & Therapy · 2011 · 76 citations · Full text

Medicine, Immunology, Pharmacology +17

Depletion of Autoreactive Plasma Cells and Treatment of Lupus Nephritis in Mice Using CEP-33779, a Novel, Orally Active, Selective Inhibitor of JAK2

Lily Lu, Kristine L. Stump, Nate H. Wallace et al. · The Journal of Immunology · 2011 · 75 citations · Full text

Medicine, Immunology, Pharmacology +16

Novel, orally active, proteasome inhibitor, delanzomib (CEP-18770), ameliorates disease symptoms and glomerulonephritis in two preclinical mouse models of SLE

Matthew M. Seavey, Lily Lu, Kristine L. Stump et al. · International Immunopharmacology · 2011 · 58 citations

Medicine, Medicinal Chemistry, Nephrology +16

Therapeutic Efficacy of CEP-33779, a Novel Selective JAK2 Inhibitor, in a Mouse Model of Colitis-Induced Colorectal Cancer

Matthew M. Seavey, Lily Lu, Kristine L. Stump et al. · Molecular Cancer Therapeutics · 2012 · 41 citations

Medicine, Oncology, Pharmacology +17

Characterization of a full-length infectious cDNA clone and a GFP reporter derivative of the oncolytic picornavirus SVV-001

John T. Poirier, P. Seshidhar Reddy, Neeraja Idamakanti et al. · Journal of General Virology · 2012 · 29 citations

Life Sciences, Biology, Molecular Biology +14

1–5 of 8